Cargando…
Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential
Aldehyde dehydrogenase (ALDH) has recently been shown to be a marker of cancer stem-like cells (CSCs) across tumour types. The primary goals of this study were to investigate whether ALDH is expressed in liposarcomas, and whether CSCs can be identified in the ALDH(high )subpopulation. We have demons...
Autores principales: | Stratford, Eva W, Castro, Russell, Wennerstrøm, Anna, Holm, Ruth, Munthe, Else, Lauvrak, Silje, Bjerkehagen, Bodil, Myklebost, Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351708/ https://www.ncbi.nlm.nih.gov/pubmed/22612877 http://dx.doi.org/10.1186/2045-3329-1-8 |
Ejemplares similares
-
Characterization of Liposarcoma Cell Lines for Preclinical and Biological Studies
por: Stratford, Eva W., et al.
Publicado: (2012) -
Accurate 3-gene-signature for early diagnosis of liposarcoma progression
por: Serguienko, Anastassia, et al.
Publicado: (2020) -
Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma
por: Hanes, Robert, et al.
Publicado: (2016) -
The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines
por: Wessel Stratford, Eva, et al.
Publicado: (2014) -
Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma
por: Hanes, Robert, et al.
Publicado: (2019)